Patients with COPD who were hospitalized for acutely worsening respiratory symptoms had a prevalence of pulmonary embolism of 5.9%.
Duration-dependent beneficial effects of metformin, sulfonylurea, and thiazolidinedione use on COPD exacerbation have been observed in patients with COPD and diabetes.
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate may reduce the risk of death compared with glycopyrrolate/formoterol fumarate in patients with COPD.
The prevalence of chronic neck pain and chronic low back pain has been shown to be higher in patients with COPD compared with individuals without COPD.
An analysis of real-world data demonstrated that patients taking fluticasone propionate-salmeterol for COPD had outcomes that closely matched results of randomized controlled trials.